EXTON, Pa., March 2 /PRNewswire-FirstCall/ -- ViroPharma Incorporated today announced that it will present at the Cowen & Company 26th Annual Health Care Conference at 4:00 P.M. Eastern Time on Tuesday, March 7th, 2006. The conference is being held at the Boston Marriott Copley Place in Boston, Massachusetts.
In addition, the company will also present at the 5th Annual JMP Securities Research Conference at 8:05 A.M. Pacific Time (11:05 A.M. Eastern Time) on Wednesday, March 8th, 2006. The conference is being held at the Ritz-Carlton Hotel in San Francisco, California.
ViroPharma's presentations will be webcast live for investors through http://www.viropharma.com, and available for replay for a period of 14 days following the conference.
About ViroPharma Incorporated
ViroPharma Incorporated is committed to the development and commercialization of products that address serious diseases treated by physician specialists and in hospital settings. ViroPharma commercializes Vancocin(R) approved for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information, please download the package insert at http://www.viropharma.com/docs/pulvules_pi.pdf). ViroPharma currently focuses its drug development activities in viral diseases including cytomegalovirus (CMV) and hepatitis C (HCV). For more information on ViroPharma, visit the company's website at http://www.viropharma.com.
ViroPharma IncorporatedCONTACT: Will Roberts, Director, Corporate Communications, ViroPharma,+1-610-321-6288
Web site: http://www.viropharma.com/
